In addition, p53 apoptotic activation can be achieved by zinc combination with low-dose doxorubicin (ADR) that used alone does not achieve such effect; mechanistically, zinc supplementation reduces the p53 binding to MDM2, improving the low-dose drug-induced cytotoxic effect and cancer cell apoptosis [151]. Here, MDM2 is linked to cancer.